India is the fourth-largest exporter of drugs and biologics to the US with bilateral trade growing from $13.5bn (€10bn) in 2001 to $32bn in 2006. The offices, which will be opened on January 15, will ensure that the production practices of local drugmakers are compliant with the requirements of the US market.



